← Back to dossier
Patient handout

Haemorrhoidal Disease & Common Benign Anorectal Conditions (internal/external haemorrhoids Goligher I–IV, thrombosed external haemorrhoid, acute anal fissure, perianal abscess pointer) — rectal bleeding NOT assumed benign

PRODUCTION

1. Your condition

This handout is for haemorrhoidal disease & common benign anorectal conditions (internal/external haemorrhoids goligher i–iv, thrombosed external haemorrhoid, acute anal fissure, perianal abscess pointer) — rectal bleeding not assumed benign. Your care team identified this based on: bright-red blood on stool / paper / dripping — not assumed haemorrhoidal until colorectal source excluded (siminoff 2015 pmid 26504796; ascrs 2024).

Other reasons your team may use this plan: perianal lump / prolapsing tissue with defecation (internal haemorrhoid grading) (ascrs 2024); acute severe perianal pain — thrombosed external haemorrhoid vs anal fissure vs perianal abscess pivot (greenspon 2004 pmid 15486746; ascrs 2023); pruritus ani / mucous discharge / soiling (haemorrhoidal symptom or alternative anorectal pathology) (ascrs 2024).

2. Your medications

Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.

MedicationStarting doseHowWhenWhat it does
fibre_fluids_bowel_habit_modificationIncrease dietary fibre + fluids; avoid straining/prolonged toilet sittingdietarycontinuousASCRS 2024 strong recommendation; Cochrane (Alonso-Coello CD004649 PMID 16235372) + meta-analysis (PMID 16405552) — fibre roughly halves risk of persistent symptoms/bleeding (RR ~0.50)
sitz_bathsWarm sitz bath 10–15 min, 2–3×/day esp. after defecationtopicalPRN/2-3x dailyASCRS 2024/2023 — relieves sphincter spasm/discomfort; safe in pregnancy; adjunct for fissure and conservatively-managed thrombosed external haemorrhoid
psyllium3.4–7 g/day, titrate; with adequate fluidPOdailyASCRS 2024 — soluble bulk fibre of choice; symptom/bleeding benefit (Alonso-Coello AJG 2006 PMID 16405552); pregnancy-safe
methylcellulose2 g PO 1–3×/day with waterPO1-3x dailyASCRS 2024 — alternative bulk-forming fibre when psyllium poorly tolerated; same symptom benefit class
polyethylene glycol 335017 g in 240 mL water daily, titratePOdailyASCRS 2024 — osmotic laxative to soften stool and reduce straining when fibre alone insufficient; pregnancy-acceptable
lactulose15–30 mL PO daily, titratePOdailyASCRS 2024 — osmotic-laxative alternative; commonly used in pregnancy for constipation contributing to haemorrhoids
docusate100 mg PO BIDPOBIDASCRS 2024 — stool softener adjunct to reduce straining (modest evidence; used as adjunct not monotherapy)
acetaminophen500–1000 mg PO q6h (max 3 g/day)POq6h PRNASCRS 2024 — preferred analgesic; pregnancy-safe first-line for anorectal pain
ibuprofen400 mg PO q6–8h PRN, short coursePOq6-8h PRNASCRS 2024 — short-course NSAID for thrombosed-external/post-procedure pain; AVOID in pregnancy (esp. 3rd trimester) and GI-bleeding risk

Plan: Haemorrhoid stepwise management — conservative → symptomatic topical/venotonic → procedural escalation (ASCRS 2024 + Cochrane fibre/laxatives/phlebotonics + Shanmugam/HubBLe/eTHoS/Greenspon)

3. When to call your provider

Contact your care team if any of the following happen:

  • Any alarm feature / iron-deficiency anaemia / atypical-persistent bleeding → colorectal-source workup / GI referral (Siminoff 2015 PMID 26504796)
  • Grade III–IV / refractory grade I–III → colorectal referral for office procedure or surgery (ASCRS 2024)
  • Acutely thrombosed external haemorrhoid with severe pain <72 h → ED for excision (Greenspon PMID 15486746)
  • Perianal abscess / fever / perianal sepsis (esp. immunocompromised/diabetic) → ED surgical emergency (ASCRS 2023)
  • Non-healing / lateral / multiple fissure → secondary-cause workup + colorectal referral (ASCRS 2023)

4. When to seek emergency care

Call 911 or go to the nearest emergency room right away if you have:

  • THE load-bearing colorectal-cancer rule (§5.5.2 LR+ ≥20) that OVERRIDES "it is just haemorrhoids." Painless bright-red blood that coats / drips and is clearly distal-anorectal (haemorrhoid pattern) carries a LOW likelihood ratio for CRC (binned LR+ ≈ 0.3–0.5 — it argues AWAY from cancer in an otherwise asymptomatic screened patient). The pivot to colonoscopy fires when bleeding is mixed with stool / dark / altered OR co-occurs with an alarm feature. Reference-standard = colonoscopy + histology; designs = primary-care prospective/population cohorts + SR. Pre-test priors (cohort): unselected rectal bleeding in primary care PPV(CRC) ≈ 2.2–8% (Astin/Hamilton SR pooled PPV 8.1%, 95% CI 6.0–11 at age ≥50 — PMID 21619747; du Toit/Wauters BMJ 2006 PMID 16790459 ~5.7% CRC, 4.9% adenoma in new-onset bleeding). The HIGHEST-LR finding mandating colonoscopy: rectal bleeding COMBINED WITH a change in bowel habit — Hamilton Br J Cancer 2006 (PMID 16882123) PPV rises into the ~double-digit range and the COMBINATION carries the dominant single-/combined-symptom likelihood ratio for CRC (binned LR+ ≈ 20+ vs the painless-pure-haemorrhoidal pattern in screened patients; rectal bleeding + change-in-bowel-habit is the diagnostic-accuracy SR top single combination — PMID 19935790, 37948886). Encoded pivot: PAINLESS-BRIGHT-RED-DISTAL → benign attribution permitted ONLY after the conditional checks below; ANY alarm feature, atypical/mixed bleeding, or iron-deficiency anaemia → CRC posterior dominates → mandatory colonoscopy BEFORE benign attribution (Siminoff PMID 26504796 — haemorrhoid attribution is the single most common missed CRC diagnostic opportunity, 36.5% missed-dx rate; ~80% of misattributions GI-GU incl. haemorrhoids). CONDITIONAL DEPENDENCIES (≥4, NOT independent): (1) CRC posterior PPV is conditional on AGE — same bleeding at <50 yr OR≈1 vs 50–69 OR≈5.1 vs ≥70 OR≈8.2 (PMID 16790459/16882123); the colonoscopy threshold drops at age ≥45 (current screening start). (2) Bleeding-attribution ERROR is conditional on ANOSCOPY/proctoscopy actually being performed AND a visible bleeding haemorrhoid identified — without endoscopic confirmation the "haemorrhoid" label is unsupported and the CRC posterior is NOT discounted (Siminoff PMID 26504796). (3) BLEEDING SEVERITY is conditional on anticoagulant/antiplatelet therapy — antithrombotic agents amplify both haemorrhoidal and occult-tumour bleeding, so heavy bleeding on anticoagulation is LESS discriminating for CRC and more discriminating for procedural risk (PMID 19095121 late post-band bleeding on antithrombotics; PMID 36048039 post-haemorrhoidectomy bleeding 5.92% on antithrombotic vs 2.66% not). (4) The lesion identity (haemorrhoid vs anorectal varix) is conditional on LIVER DISEASE / portal hypertension — in cirrhosis a dilated anorectal vessel is a VARIX, the haemorrhoid prior collapses, and banding/injection is contraindicated (route gi.cirrhosis.core.v1 / gi.variceal_bleed.v1). INDEPENDENCE NOTE: age and family-history-CRC contribute approximately independently to the pre-test prior (multiply); bowel-habit change and bleeding are NOT independent of an underlying tumour (their co-occurrence is the high-LR constellation, not a simple product). Threshold rule: colonoscopy mandated when (age ≥45) OR (any alarm feature) OR (iron-deficiency anaemia) OR (atypical/persistent/mixed bleeding) OR (no anoscopic haemorrhoidal source identified) OR (incomplete prior screening) — benign attribution is permitted ONLY when ALL are absent (Siminoff PMID 26504796; ASCRS 2024 PMID 38294832).
  • Rectal bleeding WITH any alarm feature — age ≥45 / per current screening, change in bowel habit, weight loss, iron-deficiency anaemia, family history CRC/IBD, bleeding atypical for haemorrhoids, incomplete prior screening, persistent/atypical bleeding (Siminoff 2015 PMID 26504796; ASCRS 2024)
  • Symptomatic / significant iron-deficiency anaemia attributable to chronic anorectal bleeding (ASCRS 2024)
  • Perianal abscess / perianal sepsis / Fournier gangrene (esp. diabetic / immunocompromised) (ASCRS 2023)(life-threatening)

5. Follow-up

Recurrence counselling + sustained bowel-habit/fibre maintenance; CONFIRM age-appropriate colorectal cancer screening is completed/up to date (the safety close-out — never close a rectal-bleeding episode without it); pregnancy postpartum resolution counselling (most resolve); escalate non-responders to colorectal referral; route IBD (gi.crohns.core.v1), portal-HTN/varices (gi.cirrhosis.core.v1), or malignancy as identified (ASCRS 2024/2023)

6. Sources

Guideline: ASCRS 2024 Clinical Practice Guidelines for the Management of Hemorrhoids (Hawkins, Dis Colon Rectum 2024) + ASCRS 2023 Clinical Practice Guidelines for the Management of Anal Fissures (Davids, Dis Colon Rectum 2023) + ACG/ESCP + Cochrane (fibre/laxatives, RBL vs haemorrhoidectomy, phlebotonics, non-surgical anal fissure)

  1. pubmed.ncbi.nlm.nih.gov/38294832
  2. pubmed.ncbi.nlm.nih.gov/36321851
  3. pubmed.ncbi.nlm.nih.gov/29420423